Navigation Links
Interferon Reduces, Eliminates Viral Infections in Heart Failure Patients
Date:11/11/2008

Study highlights:

- Interferon eliminated specific causes of some viruses in heart failure patients, improving their clinical outcomes.

- Treatment improved cardiac function and quality of life and showed no apparent safety concerns.

NEW ORLEANS, Nov. 11 /PRNewswire-USNewswire/ -- Giving interferon to heart failure patients with evidence of a chronic viral infection safely eliminated two viruses from their systems and reduced levels of a third virus. Additionally, there were trends toward improved cardiac function and quality of life, but these did not reach significance at 24 weeks, researchers reported at the American Heart Association's Scientific Sessions 2008. Results from the Effect of Subcutaneous Treatment with Interferon-Beta-1b over 24 weeks on Safety, Virus Elimination and Clinical Outcome in Patients with Chronic Viral Cardiomyopathy study were presented as a late-breaking clinical trial.

"These results from our randomized trial provide the first evidence that interferon beta-1b (IFNB-1b) treatment eliminates cardiotropic viruses and may improve the clinical outcomes of patients with chronic enteroviral and adenoviral heart disease," said Heinz Peter Schultheiss, M.D., the lead author of the study and a professor of medicine in the Department of Cardiology and Pneumology at Charite - University Medicine of Berlin, Campus Benjamin Franklin in Berlin, Germany.

The double-blind Phase II study included 143 patients at 31 medical centers in seven European countries.

Investigators also found a reduction in the viral load for parvovirus, but not evidence for elimination.

Researchers found that patients infected with adenovirus, enterovirus and/or parvovirus B19 who received IFNB-1b were about twice as likely to have improved symptoms 12 weeks after treatment ended. They found that 38.6 percent of the interferon patients had an improved New York Heart Association (NYHA) functional classification as compared
'/>"/>

SOURCE American Heart Association
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Study shows that high-dose, high-frequency interferon produces no additional benefit
2. GenOdyssee Receives Notice of Allowance from U.S. Patent Office for Improved Interferon-Alpha Aimed at Hepatitis C
3. PEGINTRON(TM) and REBETOL(R) Approved in European Union for Retreating Hepatitis C Patients Who Failed Previous Pegylated or Non-Pegylated Interferon Therapy
4. Interferon does not slow or stop hepatitis C from worsening, study finds
5. For the First Time this Winter Consumers Have an Electronic Green Solution that Eliminates 99.97 Percent of Indoor Air Pollution
6. Ultra-High Pressure Processing Eliminates Salmonella in Fresh Tomatoes
7. Radian Guaranty Inc. Eliminates Stated Income and Stated Asset Programs
8. Verathon Inc. Introduces GlideScope(R) Ranger Single Use Video Laryngoscope for Emergency Departments, EMS and Military; Enables Fast Intubations and Eliminates Time-Consuming Disinfection
9. Roche Receives FDA Approval for Hepatitis C Viral Load Test on Its Fully Automated Real-Time PCR Platform
10. Doctor Recommends New Powerful Natural Antiviral Against the Flu
11. Researchers estimate lives lost due to delay in antiretroviral drug use for HIV/AIDS in South Africa
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... Calif. (PRWEB) January 22, 2015 ... Susan Bonilla (D-Concord) and Kristin Olsen (R-Modesto) were ... their leadership in advancing biotechnology, biomedical science, medical ... and Olsen each received the “2014 Life Sciences ...
(Date:1/22/2015)... City, Florida (PRWEB) January 22, 2015 IsoComforter, ... cold therapy machine with patented IsoTube design to treat specific ... has introduced the most progressive and easy to use patented ... treat post-operative and sports related orthopedic and muscle injuries. ...
(Date:1/22/2015)... Payday lending practices in four southern states ... distress to the states that permit them, according to ... on Race and Wealth. , While they generate hundreds ... at the same time substantially depress economic activity, according ...
(Date:1/22/2015)... 22, 2015 As interest in the value ... gains momentum worldwide, Rev. Eric J. Hall , president ... (HCCN), will be the keynote speaker on January 27 ... public health system. , The conference, “Hope and Resilience: Innovative ...
(Date:1/22/2015)... Compare-autoinsurance.org has released a new blog post presenting a list ... policy . , Some types of vehicles cannot be covered ... released blog post to see if their vehicle qualifies for auto ... some of the cars that cannot be covered by a plan. ...
Breaking Medicine News(10 mins):Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 3Health News:IsoComforter Introduces Best of Class Cold Therapy Product to the Worldwide Market 2Health News:Howard University Spotlights the Economic Impact of Payday Lending in Southern States 2Health News:HealthCare Chaplaincy CEO to Keynote Spiritual Care Summit in Israel 2Health News:HealthCare Chaplaincy CEO to Keynote Spiritual Care Summit in Israel 3Health News:Some Vehicles Cannot Be Covered By An Auto Insurance Policy! 2
... Women and Men From 46 States and 7 ... ... participants in this,weekend,s fifth annual Avon Walk for Breast Cancer New York ... breast cancer. At,today,s Closing Ceremony at Hudson River Park,s Pier 84, Avon ...
... Prognosis improves in summer, fall, study finds , SUNDAY, Oct. ... the summer and fall have a better chance of survival ... study of Norwegian men suggests. , "Summer and autumn months ... Although the study does not prove vitamin D is the ...
... is linked to MRI exposure, scientists say , FRIDAY, ... a newly identified disease called nephrogenic systemic fibrosis (NSF) ... , The researchers also concluded that exposure to gadolinium, ... significant risk factor for developing NSF, a painful and ...
... groups,affiliated and aligned with Sutter Health have been ... highly respected health care leadership,group, the Integrated Healthcare ... annual Pay for Performance (P4P) report card. ... Regional Medical Group of the Sutter Regional Medical ...
... in Dallas-Ft. Worth, Hartford and Sacramento Markets, CHICAGO, Oct. 5 , Why: ... U.S. soldiers involved in the conflicts in ... Brain Injury (TBI), with 25 percent of blast ... blast survivors, leaving 5,500 service members with ...
... cancer, aside from non-melanoma,skin cancer, is the most common ... Disease Control and Prevention. It is the number one ... most in white, black,Asian/Pacific Islander and American Indian/Alaska Native ... just those who have been diagnosed,with it. (See ...
Cached Medicine News:Health News:Fifth Annual Avon Walk for Breast Cancer New York Raises $10.2 Million 2Health News:Fifth Annual Avon Walk for Breast Cancer New York Raises $10.2 Million 3Health News:Prostate Cancer Survival Varies by Season 2Health News:New Kidney Disease Can Be Fatal 2Health News:Sutter Health Medical Groups Among the Best for Health Care Quality 2Health News:Easter Seals Launches Program for Veterans Returning from Iraq and Afghanistan with Traumatic Brain Injuries 2Health News:Easter Seals Launches Program for Veterans Returning from Iraq and Afghanistan with Traumatic Brain Injuries 3
(Date:1/23/2015)... Jan. 23, 2015  HyGreen, Inc., a leader in hand ... with RCA Medical, a subsidiary of Ascendis Health Limited, ... Each year, hundreds of millions of patients around ... organisms are transmitted from patient to patient via the ...
(Date:1/23/2015)... Cord Blood America, Inc. ( www.cordblood-america.com ) (OTC Bulletin Board: ... Preliminary Proxy Statement, Schedule 14A, with the U.S. Securities & ... for shareholders detailing why a "YES" vote to increase the ... As we reflect upon the 2014 fiscal year ...
(Date:1/23/2015)... Gem Pharmaceuticals announced today that the initial soft tissue ... Phase 2 clinical trial.  This open-label study will assess ... (an investigational medication), in approximately 30 adults as first-line ... Logo - http://photos.prnewswire.com/prnh/20150123/170966LOGO GPX-150 is ...
Breaking Medicine Technology:HyGreen Partners with RCA Medical in Johannesburg, South Africa 2Cord Blood America Announces Preliminary Proxy Filing and Details Why a "YES" Vote to Increase Authorized Shares Is Requested 2Cord Blood America Announces Preliminary Proxy Filing and Details Why a "YES" Vote to Increase Authorized Shares Is Requested 3Cord Blood America Announces Preliminary Proxy Filing and Details Why a "YES" Vote to Increase Authorized Shares Is Requested 4Gem Pharmaceuticals Announces Enrollment of Initial Patients in its Phase 2 Clinical Trial to Assess the Efficacy and Safety of GPX-150 in Sarcoma Patients 2
... Oct. 3, 2011 Varian Medical Systems (NYSE: ... senior managers to support the company,s ongoing growth and ... Vice President for the company, has been named Chief ... development, production, promotion, and sale of all Varian products ...
...   PLC Medical Systems, Inc. (OTC: PLCSF) today announced ... , October 6, 2011TIME: , 11:00 AM ... "register/ watch event now" button.This will be a live, ... the company questions in real-time both in the presentation ...
Cached Medicine Technology:Varian Medical Systems Announces New Management Positions 2Varian Medical Systems Announces New Management Positions 3Varian Medical Systems Announces New Management Positions 4PLC Medical Systems to Present Webcast Live, at RetailInvestorConferences.com on October 6th 2
For the direct, colorimetric determination of calcium in human serum or urine. Linearity: 20 mg/dl....
Alanine Aminotransferase (ALT) reagent is used for the quantitative determination of alanine aminotransferase (Glutamate pyruvate transaminase, SGPT) in human serum....
For the quantitative determination of Alanine Aminotransferase in serum. Optimized IFCC without P-5'-P, Linearity: 500 IU/L at 37 C. Liquid Working Reagent prepared with simple 1:9 dilution....
For the determination of urea nitrogen in human serum....
Medicine Products: